Paper · 2990664

Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.

Burger PC and 3 others. Cancer, 1985. Cited by 577 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Papers, record 2990664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2990664

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.; PubMed
Journal: Cancer; PubMed
Year: 1985; PubMed
Publication types: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/2990664/; PubMed
DOI: https://doi.org/10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2; PubMed
The journal: https://conductscience.org/library/journal-index/0374236; PubMed
Citations, by iCite: 577; iCite
Relative citation ratio, by iCite: 17.2; iCite
Revised in PubMed: 2022-03-30; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Burger PC	P C
2	Vogel FS	F S
3	Green SB	S B
4	Strike TA	T A

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Astrocytoma	Major topic
Brain Neoplasms	Major topic
Glioblastoma	Major topic
Actuarial Analysis
Adolescent
Adult
Age Factors
Aged
Humans
Middle Aged
Prognosis
Random Allocation

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
N01-CM-57020	NCI NIH HHS	United States	N01CM057020	PubMed and NIH	NIH RePORTER
U10-CA36005-01	NCI NIH HHS	United States	U10CA360050	PubMed	NIH RePORTER
			U10CA036005	NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by155

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 577 citations.

PMID	Title	Journal	Year	In Papers	Source
39,880,824	Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.	Nat Commun	2025	https://conductscience.org/library/papers/39880824	PubMed
37,555,870	Treatment with quercetin increases Nrf2 expression and neuronal differentiation of sub ventricular zone derived neural progenitor stem cells in adult rats.	Mol Biol Rep	2023	https://conductscience.org/library/papers/37555870	PubMed
36,791,206	Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy.	Sci Transl Med	2023	https://conductscience.org/library/papers/36791206	PubMed
36,292,183	Differentiation of Intracerebral Tumor Entities with Quantitative Contrast Attenuation and Iodine Mapping in Dual-Layer Computed Tomography.	Diagnostics (Basel)	2022	https://conductscience.org/library/papers/36292183	PubMed
35,606,665	A Comparative Study Between Tumor Blood Vessels and Dynamic Contrast-enhanced MRI for Identifying Isocitrate Dehydrogenase Gene 1 (IDH1) Mutation Status in Glioma.	Curr Med Sci	2022	https://conductscience.org/library/papers/35606665	PubMed
35,270,016	Synthesis of MIL-Modified Fe3O4 Magnetic Nanoparticles for Enhancing Uptake and Efficiency of Temozolomide in Glioblastoma Treatment.	Int J Mol Sci	2022	https://conductscience.org/library/papers/35270016	PubMed
34,522,709	The multifaceted PDCD10/CCM3 gene.	Genes Dis	2021	https://conductscience.org/library/papers/34522709	PubMed
33,654,565	Bibliometric analysis of the top 100 most-cited articles on astrocytoma.	Surg Neurol Int	2021	https://conductscience.org/library/papers/33654565	PubMed
33,595,778	Analysis of the P53N a Novel Protein Encoded on Chromosome 22q12.1-12.3 in Glioblastomas and Ependymomas Specimens.	J Mol Neurosci	2021	https://conductscience.org/library/papers/33595778	PubMed
32,898,338	ΔNp63 drives epithelial differentiation in glioma.	Clin Transl Med	2020	https://conductscience.org/library/papers/32898338	PubMed

1 to 10 of 155

See all 155 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2990664

GET https://conductscience.org/api/papers/v1/2990664/cited_by?page=2

API reference For AI assistants